retatrutide triple agonist gip glp-1 glucagon phase 3 2025 What GLP‑3 Really Is: Triple‑Receptor Drug Retatrutide (Eli Lilly's triple GLP-1/GIP/Glucagon
Description
Appetite and craving support
Learn the science behind Ozempic, Wegovy, and more.
Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors
Bioavailable forms of Vitamin B12, L-Methylfolate, and CoQ10 are packed into each capsule to support energy production at the cellular level
Semaglutide works in a similar way by helping to slow down how quickly food leaves the stomach and by acting on areas of the brain involved in appetite control
